In several mouse models of colitis, specific delivery of the protein to the colon provided therapeutic and prophylactic protection.
The authors said their data provide a rationale for development of probiotic-derived proteins as reagents for preventing and treating ulcerative intestinal inflammatory disorders.
Read the Journal of Clinical Investigation abstract on gastrointestinal disorders.
Related Articles on Intestinal Disorders:
Studies Find Dramatic Uptick in Prostate Biopsy Infections
Bacteria in Gut Linked to Brain Chemistry, Behavior
23% of Gastroenterologists Cannot Name Criteria for Diagnosing Barrett’s Esophagus
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
